Dr. Brad Bolzon

Dr. Bradley Bolzon has served on our Board of Directors since November 2013. Brad currently serves as a Managing Director of Versant Venture Management LLC, where he has been employed since May 2004. Additionally, he served as a member of the Board of Directors of Flexion Therapeutics from its inception in 2007 to June 2014. From February 2000 to May 2004, Brad served as Executive Vice President, Global Head of Business Development, Licensing & Alliances of Roche. Brad also formerly served as Head of Cardiovascular Research at Eli Lilly. He received a Ph.D. and M.S. in Pharmacology from the University of Toronto and did his post-doctoral work at the University of Ottawa Heart Institute.